case_images: PMC3804584_01
case_images: The changes in glucose metabolism using FDG-PET before and after selegiline treatment.. Notes: (A) Before selegiline treatment, the patient's 17-item HDRS score was 19 points; (B) after 20 weeks of selegiline treatment, a 17-item HDRS score was 4 points. Selegiline treatment increased glucose metabolism in the bilateral basal ganglia (red arrows) and decreased glucose metabolism in the occipital lobe (white arrows).. Abbreviations: FDG-PET, [18F]-fluorodeoxyglucose positron emission tomography; HDRS, Hamilton Depression Rating Scale; MRI, magnetic resonance imaging.
case_images: ndt-9-1591Fig1.jpg
case_images: PMC3804584_01_ndt-9-1591Fig1.jpg
case_images: f1-ndt-9-1591
case_images: Twenty weeks after selegiline treatment, selegiline-induced enhancement of glucose metabolism was observed in the bilateral basal ganglia by FDG-PET, while decreases were shown in those in the occipital lobe (Figure 1).